Pnc Financial Services Group, Inc. Fennec Pharmaceuticals Inc. Transaction History
Pnc Financial Services Group, Inc.
- $150 Billion
- Q2 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 112 shares of FENC stock, worth $560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112Holding current value
$560% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding FENC
# of Institutions
65Shares Held
14.3MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$20.4 Million0.73% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$12 Million30.37% of portfolio
-
Dg Capital Management, LLC New York, NY1.63MShares$8.17 Million3.85% of portfolio
-
Solas Capital Management, LLC Darien, CT1.34MShares$6.7 Million4.92% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$5.94 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $130M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...